Loading clinical trials...
Loading clinical trials...
The purpose of this study is to show that addition of device use to a routine breast cancer tumor excision procedure is beneficial and assists the surgeon in correctly determining the extent of excision.
The study is a prospective, multi-center, randomized, double arm study demonstrating the effectiveness of the device in adjunctive use for locating the tissue for additional excision following primary specimen excision. One arm is a "Standard of Care" (SOC) Control group and the other arm a "Device+SOC" group.In the "Device +SOC" group the surgeon will use the MarginProbe device on the tissue specimen removed during the surgical procedure.The surgeon will use the results derived from the device and other routine assessments to decide if it is necessary to remove some additional breast tissue.
Age
18 - 90 years
Sex
FEMALE
Healthy Volunteers
No
Pacific Breast Care
Costa Mesa, California, United States
University of Southern California
Los Angeles, California, United States
Cedars Sinai Hospital
Los Angeles, California, United States
HOAG Memorial Hospital
Newport Beach, California, United States
St. Joseph Hospital
Orange, California, United States
UCIrvine Medical Center
Orange, California, United States
Georgetown University Hospital
Washington D.C., District of Columbia, United States
Anne Arundel Medical Center
Annapolis, Maryland, United States
Mercy Hospital Services
Baltimore, Maryland, United States
Franklin Square Hospital Center
Baltimore, Maryland, United States
Start Date
October 1, 2008
Primary Completion Date
March 1, 2010
Completion Date
June 1, 2010
Last Updated
June 27, 2014
664
ACTUAL participants
MarginProbe
DEVICE
Lumpectomy
PROCEDURE
Lead Sponsor
Dune Medical Devices
NCT05673200
NCT04704661
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions